| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
For fiscal year 2024, the Company projects approximately: Net sales of $2.95 billion to $3.0 billion ($2.95 billion in fisca...
For the second quarter of fiscal 2024, the Company expects approximately: $560 million to $570 million in net sales ($600 mi...
Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:GILD) with a Hold.
JP Morgan analyst Jeffrey Zekauskas upgrades Dow (NYSE:DOW) from Neutral to Overweight and raises the price target from $55 ...
Tesla in December recalled 2.03 million vehicles equipped with all versions of Autosteer after deeming the feature's contro...
Wolfe Research analyst Deepak Mathivanan maintains Alphabet (NASDAQ:GOOGL) with a Outperform and raises the price target fro...
As the “meme coin supercycle” chugs on, several traders have chipped in with lofty price predictions about which meme coins cou...
